[1] |
胡森,盛志勇. 重视战、创(烧)伤休克现场非常规救治技术研究[J]. 解放军医学杂志,2011, 36(1): 5-7.
|
[2] |
Fessler EB, Chibane FL, Wang Z, et al. Potential roles of HDAC inhibitors in mitigating ischemia- induced brain damage and facilitating endogenous regeneration and recovery [J]. Curr Pharm Des, 2013, 19(28): 5105-5120.
|
[3] |
Granger A, Abdullah I, Huebner F, et al. Histone deacetylase inhibition reduces myocardial ischemia- reperfusion injury in mice [J]. FASEB J, 2008, 22(10): 3549-3560.
|
[4] |
Gonzales ER, Chen H, Munuve RM, et al. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock[J]. J Trauma, 2008, 65(3): 554-565.
|
[5] |
Cianciolo CC, Skrypnyk NI, Brilli LL, et al. Histone deacetylase inhibitor enhances recovery after AKI[J]. J Am Soc Nephrol, 2013, 24(6): 943-953.
|
[6] |
Sun J, Wang F, Li H, et al. Neuroprotective Effect of Sodium Butyrate against Cerebral Ischemia/Reperfusion Injury in Mice[J]. Biomed Res Int, 2015, 2015: 395895.
|
[7] |
Hu X, Zhang K, Xu C, et al. Anti- inflammatory effect of sodium butyrate preconditioning during myocardial ischemia reperfusion[J]. Exp Ther Med, 2014, 8(1): 229-232.
|
[8] |
高明娟,刘维维,王晓娜,等. 丙酮酸钠羟乙基淀粉对50%总体表面积Ⅲ度烧伤大鼠肾血流量和肾功能的影响[J/CD]. 中华损伤与修复杂志:电子版,2015, 10(5): 388-394.
|
[9] |
王洁,张心怡,郝彩丽,等. 组蛋白去乙酰化酶抑制剂的研究进展[J]. 现代生物医学进展,2014, 14(14): 2783-2785.
|
[10] |
郑金光,胡森,李芳菲,等. 伏立诺他对50% TBSA Ⅲ度烫伤大鼠脏器功能及血流量的影响[J]. 感染、炎症、修复,2014, 15(4): 195-198.
|
[11] |
王艳冰,任素萍,王庆军,等. 新型组蛋白去乙酰化酶抑制剂对缺氧损伤心肌细胞的保护作用研究[J]. 军事医学,2015, 39(1): 30-35.
|
[12] |
Luo HM, Hu S, Bai HY, et al. Valproic acid treatmet attenuates caspase- 3 activation and improves survival following lethal burn injury in a rodent model[J]. J Burn Care Res, 2014, 35(2): e93-98.
|
[13] |
Zhang L, Wan J, Jiang R, et al. Protective effects of trichostatin A on liver injury in septic mice[J]. Hepatol Res, 2009, 39(9): 931-938.
|
[14] |
Gonzales E, Chen H, Munuve R, et al. Valproic acid prevents hemorrhage- associated lethality and affects the acetylation pattern of cardiac histones[J]. Shock, 2006, 25(4): 395-401.
|
[15] |
Kilgore M, Miller CA, Fass DM, et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer′s disease[J]. Neuropsychopharmacology, 2010, 35(4): 870-880.
|
[16] |
Shin H, Lee YS, Lee YC. Sodium butyrate- induced DAPK- mediated apoptosis in human gastric cancer cells[J]. Oncol Rep, 2012, 27(4): 1111-1115.
|
[17] |
Liang X, Wang RS, Wang F, et al. Sodium butyrate protects against severe burn- induced remote acute lung injury in rats[J]. PloS one, 2013, 8(7): 191-195.
|
[18] |
Han X, Song H, Wang Y, et al. Sodium butyrate protects the intestinal barrier function in peritonitic mice[J]. Int J Clin Exp Med, 2015, 8(3): 4000-4007.
|
[19] |
Bates DO. Vascular endothelial growth factors and vascular permeability[J]. Cardiovasc Res, 2010, 87(2): 262-271.
|
[20] |
Hur J, Yang HT, Chun W, et al. Inflammatory cytokines and their prognostic ability in cases of majorburninjury[J]. Ann Lab Med, 2015, 35(1):105-110.
|
[21] |
Sawa H, Murakami H, Ohshima Y, et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells[J]. Brain Tumor Pathol, 2002, 19(2):77-81.
|